Expect a Higher Level of Clinical Support with McKesson
As an independent community oncology practice, you can rely on the people at McKesson. While you focus on patient care, we clear the path with solutions that make practice management more manageable. From smarter comprehensive drug management and oncology clinical management technology to insightful advisors and tools, we’re ready to help your practice discover the McKesson difference.
In the rapidly changing world of healthcare, having a clear plan that takes full advantage of growth opportunities is everything. That's why, last year, 300 forward thinking practices choose a new path to make their future even brighter. They made the switch to McKesson.
They realized that with McKesson, they could expect a higher level of clinical and business support – over and above their current GPO. With over 20+ years of experience, no one has as much dedication to keeping independent oncology practices independent.
This level of partnership super charges growth – just one reason customers are over 3 times more likely to recommend McKesson over other GPOs (Hanover Research, 2023, NPS Survey)
Stay at the Forefront of Medical Advancements and Patient Care with McKesson
As oncology treatments continue to advance, it’s important to have a partner by your side to help assess which therapies may be right for your practice. New therapies, including biosimilars and bispecifics, can help expand treatment options for complex diseases, while providing substantial cost savings on expensive therapies.
Implementing and Overseeing Bispecific Therapies Can Be a Multifaceted Endeavor.
Our playbook, developed by McKesson clinical and business experts, is a meticulously curated resource that draws on the experiences of clinics that have successfully integrated bispecific infusion therapies. This comprehensive guide offers valuable insights and best practices to assist you in effectively exploring, launching, and managing bispecific therapies into your community oncology practice.
Revolutionizing Treatment with Bispecific Therapies
As the integration of bispecific antibodies into precision medicine becomes more common within community practices, it’s vital to implement best practices to ensure program success and optimal patient care.
Read more about strategies for successful integration of bispecifics in community oncology practices in a recent Pharmacy Times article by our clinical experts Derek Burns, PharmD, MBA, BCPS, BCSCP, and Connie Suen, PharmD, BCOP.
Clinical Support for New Therapy Adoption
Experts who support your adoption of new therapies
Our advisors can help you drive clinical value for better patient outcomes through education, training and customized consulting services, including
Advanced practice provider (APP) onboarding course to speed up orientation and time to impact
One-on-one clinical guidance and best practices to drive success in patient care
Financial insights to determine cost and reimbursement data and potential impact due to reimbursement changes
Drug economics to support productivity and identify opportunities for improvement
Practice operations improvements with pharmacy management and operations experts
Meet the Experts
Julie Cothren
Sr.
Director
Clinical Services
- Over 30 years pharmacy practice experience
- Previous Director of Pharmacy for West Cancer Center
- Subject matter expert in clinical initiatives within oncology and multispecialty clinics
Tim Ho
Director
Clinical Services
- Previous Director of Pharmacy for Illinois Cancer Center
- MBA
- Board certified Oncology Pharmacist
- Served as a disaster response pharmacist in the Air National Guard
- Pharmacy data and analytics
- Clinical education
Lisa Lasita
Director
Clinical Services
- Previous Director of Operations for Oncology Hematology Care of Cincinnati
- MBA
- Strategic planning
- Clinical education
- Workflow efficiencies
Jane Satero
Director
Clinical Services
- Previous Director of Pharmacy for Ironwood Oncology
- MBA
- Board Certified Oncology Pharmacist
- Strategic planning
- Clinical education
- Workflow efficiencies
Connie Suen
Director
Clinical Services
- Previous Clinical Pharmacy Manager for Texas Oncology in Austin
- Previous clinical research experience with Sarah Cannon
- Board certified Oncology Pharmacist
- Strategic planning
- Clinical Education
Bob Zutaut
Director
Clinical Services
- Previous Director of Pharmacy for Beckley Oncology
- Over 20 years experience in oncology pharmacy
- Strategic planning
- Pharmacy data and analytics
- Workflow efficiencies
Offering value-added support for your practice by
Supercharge Your Purchasing Power with Onmark® United
Unlock affordable, high-quality cancer care with an exclusive GPO program built for oncology.
Empower your independent practice by tapping into one of the largest aggregators of oncology drug products in the U.S. with $5 billion in annual purchasing power and two dozen differentiated contracts. In over four years, membership has grown by 146%, fueling 163% growth in purchasing power.
Expect More from Your GPO
Discover how Millennium Physicians' enduring partnership with McKesson and their Onmark United membership have been pivotal for them to sustain their practice and make essential medications available for patients in rural areas.
Be part of a $5 billion purchasing group led by 60+ independent practices
Experience differentiated economics on most expensive, widely used oncology drugs
Stay at the forefront of medical advancements with access to novel therapies
Gain a strategic partner focused on your practice’s long-term success
Contact us
Join hundreds of oncology leaders who saw the future more clearly and charted a course to sustained growth.
Make the switch and experience the McKesson difference today.
© 2025 McKesson Corporation | Cookie Settings